Thromb Haemost 2008; 100(05): 857-863
DOI: 10.1160/TH08-02-0095
Platelets and Blood Cells
Schattauer GmbH

Glutathione regulates integrin αIIbβ3-mediated cell adhesion under flow conditions

Chalmette Ball
1   Thrombosis Research Section, Department of Medicine
,
K. Vinod Vijayan
1   Thrombosis Research Section, Department of Medicine
,
Trung Nguyen
2   Critical Care Section, Department of Pediatrics, Baylor Collage of Medicine, Houston, Texas, USA
,
Kim Anthony
1   Thrombosis Research Section, Department of Medicine
,
Paul F. Bray
3   Section of Hematology, Department of Medicine, Thomas Jefferson University, School of Medicine, Philadelphia, Pennsylvania, USA
,
David W. Essex
4   Section of Hematology-Oncology, Department of Medicine, University of Texas, Health Science Center at San Antonio, San Antonio, Texas, USA
,
Jing-fei Dong
1   Thrombosis Research Section, Department of Medicine
› Author Affiliations
Financial support: This work was supported by the NIH grants HL71895 (J.F.D), HL081613 (K.V.V), HL65229 (P.F.B) and a VA Merit Grant (DWE).
Further Information

Publication History

Received 19 February 2008

Accepted after major revision 24 August 2008

Publication Date:
22 November 2017 (online)

Summary

The platelet integrin αIIbβ3 mediates the final step of platelet aggregation that requires pre-activation through an inside-out signal initiated by agonists. Experiments conducted under static conditions using platelet-rich plasma show that platelet activation and adhesion activity of αIIbβ3 are regulated by glutathione (GSH-GSSG) redox potential.However,it remains unclear as to whether GSH-GSSG exerts its regulatory role in platelets by direct targeting of αIIbβ3 or intracellular signals that activate the integrin. A role of fluid shear stress is also not known. We examined the effects of GSH-GSSG on the adhesion of CHO cells expressing two HPA variants of human αIIbβ3 to the immobilized fibrinogen and von Willebrand factor (VWF) under flow conditions. GSH-GSSG dose-dependently reduced the number of adherent cells to fibrinogen and VWF under 2.5 dyn/cm2 of shear stress, a physical force calculated to be 110 dyne on platelets. GSH treatment also abolished the hyperadhesion activity of cells expressing the Pro33 variant of αIIbβ3.The inhibition was also observed with washed platelets. The data differ from the early observation that GSH enhanced platelet aggregation induced by sub-threshold concentrations of platelet agonists. The results suggest that GSH may have distinct effects on agonist-induced αIIbβ3 activation and on the αIIbβ3-fibrinogen or αIIbβ3-VWF bonds when exposed to fluid shear stress. They further suggest that the HPA phenotype may be redox-regulated.

 
  • References

  • 1 Harbury CB, Schrier SL. Modification of platelet sulfhydryl groups. Thromb Diath Haemorrh 1974; 31: 469-484.
  • 2 Burgess JK, Hotchkiss KA, Suter C. et al. Physical proximity and functional association of glycoprotein 1balpha and protein-disulfide isomerase on the platelet plasma membrane. J Biol Chem 2000; 275: 9758-9766.
  • 3 Essex DW. The role of thiols and disulfides in platelet function. Antioxid.Redox.Signal 2004; 06: 736-746.
  • 4 Leoncini G, Signorello MG. N-ethylmaleimide inhibition of thrombin-induced platelet aggregation. Biochem Pharmacol 1999; 58: 1293-1299.
  • 5 Jelenska MM, Kopec M. Platelet-mediated collagen and fibrin retraction: effect of prostaglandins, cyclic AMP, calcium antagonists and N-ethylmaleimide. Thromb Res 1983; 30: 499-509.
  • 6 Thomas G, Skrinska VA, Lucas FV. The influence of glutathione and other thiols on human platelet aggregation. Thromb Res 1986; 44: 859-866.
  • 7 Zucker MB, Masiello NC. Platelet aggregation caused by dithiothreitol. Thromb Haemost 1984; 51: 119-124.
  • 8 Simon DI, Stamler JS, Jaraki O. et al. Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor. Arterioscler Thromb 1993; 13: 791-799.
  • 9 Mendelsohn ME, O’Neill S, George D. et al. Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetylcysteine. J Biol Chem 1990; 265: 19028-19034.
  • 10 Keaney Jr JF, Simon DI, Stamler JS. et al. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J Clin Invest 1993; 91: 1582-1589.
  • 11 Eirin MT, Calvete JJ, Gonzalez-Rodriguez J. New isolation procedure and further biochemical characterization of glycoproteins IIb and IIIa from human platelet plasma membrane. Biochem J 1986; 240: 147-153.
  • 12 Essex DW, Li M. Redox control of platelet aggregation. Biochemistry 2003; 42: 129-136.
  • 13 Yan B, Smith JW. A redox site involved in integrin activation. J Biol Chem 2000; 275: 39964-39972.
  • 14 Yan B, Smith JW. Mechanism of integrin activation by disulfide bond reduction. Biochemistry 2001; 40: 8861-8867.
  • 15 Kamata T, Ambo H, Puzon-McLaughlin W. et al. Critical cysteine residues for regulation of integrin alphaIIbbeta3 are clustered in the epidermal growth factor domains of the beta3 subunit. Biochem J 2004; 378: 1079-1082.
  • 16 Chen K, Detwiler TC, Essex DW. Characterization of protein disulphide isomerase released from activated platelets. Br J Haematol 1995; 90: 425-431.
  • 17 O’Neill S, Robinson A, Deering A. et al. The platelet integrin alpha IIbbeta 3 has an endogenous thiol isomerase activity. J Biol Chem 2000; 275: 36984-36990.
  • 18 Lahav J, Gofer-Dadosh N, Luboshitz J. et al. Protein disulfide isomerase mediates integrin-dependent adhesion. FEBS Lett 2000; 475: 89-92.
  • 19 Manickam N, Sun X, Li M. et al. Protein disulphide isomerase in platelet function. Br J Haematol 2008; 140: 223-229.
  • 20 Peerschke EI. Regulation of platelet aggregation by post-fibrinogen binding events. Insights provided by dithiothreitol-treated platelets. Thromb Haemost 1995; 73: 862-867.
  • 21 Calvete JJ, Henschen A, Gonzalez-Rodriguez J. Assignment of disulphide bonds in human platelet GPIIIa. A disulphide pattern for the beta-subunits of the integrin family. Biochem J 1991; 274: 63-71.
  • 22 Sun QH, Liu CY, Wang R. et al. Disruption of the long-range GPIIIa Cys(5)-Cys(435) disulfide bond results in the production of constitutively active GPIIb-IIIa (alpha(IIb)beta(3)) integrin complexes. Blood 2002; 100: 2094-2101.
  • 23 Gilbert HF. Molecular and cellular aspects of thioldisulfide exchange. Adv Enzymol Relat Areas Mol Biol 1990; 63: 69-172.
  • 24 Hwang C, Sinskey AJ, Lodish HF. Oxidized redox state of glutathione in the endoplasmic reticulum. Science 1992; 257: 1496-1502.
  • 25 Anderson ME, Meister A. Dynamic state of glutathione in blood plasma. J Biol Chem 1980; 255: 9530-9533.
  • 26 Mansoor MA, Svardal AM, Ueland PM. Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal Biochem 1992; 200: 218-229.
  • 27 Jones DP. Redefining oxidative stress. Antioxid Redox Signal 2006; 08: 1865-1879.
  • 28 Lash LH, Jones DP. Distribution of oxidized and reduced forms of glutathione and cysteine in rat plasma. Arch Biochem Biophys 1985; 240: 583-592.
  • 29 Essex DW, Li M, Feinman RD. et al. Platelet surface glutathione reductase-like activity. Blood 2004; 104: 1383-1385.
  • 30 Vijayan KV, Goldschmidt-Clermont PJ, Roos C. et al. The Pl(A2) polymorphism of integrin beta(3) enhances outside-in signaling and adhesive functions. J Clin Invest 2000; 105: 793-802.
  • 31 Moake JL, Turner NA, Stathopoulos NA. et al. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest 1986; 78: 1456-1461.
  • 32 Choi H, Aboulfatova K, Pownall HJ. et al. Shear-induced disulfide bond formation regulates adhesion activity of von willebrand factor. J Biol Chem 2007; 282: 35604-35611.
  • 33 Vijayan KV, Huang TC, Liu Y. et al. Shear stress augments the enhanced adhesive phenotype of cells expressing the Pro33 isoform of integrin beta3. FEBS Lett 2003; 540: 41-46.
  • 34 Dong J, Ye P, Schade AJ. et al. Tyrosine sulfation of glycoprotein I(b)alpha. Role of electrostatic interactions in von Willebrand factor binding. J Biol Chem 2001; 276: 16690-16694.
  • 35 Fredrickson BJ, Dong JF, McIntire LV. et al. Sheardependent rolling on von Willebrand factor of mammalian cells expressing the platelet glycoprotein Ib-IX-V complex. Blood 1998; 92: 3684-3693.
  • 36 Morel MH, Redl A, Guilbert S. Mechanism of heat and shear mediated aggregation of wheat gluten protein upon mixing. Biomacromolecules 2002; 03: 488-497.
  • 37 Davis GE, Camarillo CW. Regulation of integrinmediated myeloid cell adhesion to fibronectin: influence of disulfide reducing agents, divalent cations and phorbol ester. J Immunol 1993; 151: 7138-7150.
  • 38 Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 1998; 67: 395-424.
  • 39 Akhter S, Vignini A, Wen Z. et al. Evidence for S-nitrosothiol-dependent changes in fibrinogen that do not involve transnitrosation or thiolation. Proc Natl Acad Sci USA 2002; 99: 9172-9177.
  • 40 Bandyopadhyay D, Chattopadhyay A, Ghosh G. et al. Oxidative stress-induced ischemic heart disease: protection by antioxidants. Curr Med Chem 2004; 11: 369-387.
  • 41 Cejas P, Casado E, Belda-Iniesta C. et al. Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain). Cancer Causes Control 2004; 15: 707-719.
  • 42 Ozkul A, Akyol A, Yenisey C. et al. Oxidative stress in acute ischemic stroke. J Clin Neurosci 2007; 14: 1062-1066.
  • 43 Vijayan KV, Liu Y, Souza S. et al. Fibrinogen and prothrombin binding is enhanced to the Pro33 isoform of purified integrin alphaIIbbeta3. J Thromb Haemost 2006; 04: 905-906.
  • 44 Cho J, Furie BC, Coughlin SR. et al. A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. J Clin Invest 2008; 118: 1123-1131.